Patriot Scientific

Patriot Scientific Reports Profitable Quarter; Q3 FY '08 Net Income $6.3 Million or $0.02 Basic and Diluted Earnings Per Share.
in response to PIC2021R's message

So, we are trying to strentghen the Markman.....

Yes, to some extent, but there is also just a basic element of preservation of issues that is probably the primary consideration.


I suspect that the since the ooponents are doing all then can to delay and prolong things....

Yes, again. This is common in litigation with large and/or multi-national defendants, usually as a "starve the enemy" tactic. In PTSC's case, it has certainly been so with all of the prior PTO re-exams. It is less so in the NDCA cases, since the opposing parties are the ones who instituted that litigation --- nevertheless, that was mainly a choice-of-venue consideration, and delays have occurred in other aspects thereafter.

As to any appeal from the ITC, I would refer you to prior posts by Ease on this subject.

Best wishes.

Please login to post a reply
ronran
City
Rank
President
Activity Points
30970
Rating
Your Rating
Date Joined
12/13/2004
Social Links
Private Message
Patriot Scientific
Symbol
PTSC
Exchange
OTCBB
Shares
401,392,948
Industry
Technology & Medical
Website
Create a Post